TYK Medicines, Inc Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2018)

Organization Overview

First Clinical Trial
2020
NCT04204473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

TYK Medicines, Inc